“The Role of CD-19 Targeting Chimeric Antigen Receptor (CAR) T-Cell Therapy in Non-Hodgkin Lymphoma”. High Yield Medical Reviews, vol. 2, no. 2, Dec. 2024, https://doi.org/10.59707/hymrFHJX7726.